ISoP Mid-Year Symposium
In pharmacovigilance, various scientific disciplines such as epidemiology, (clinical) pharmacology, and medical science are necessary to monitor the safe use of drugs.
The value of real-world data for ensuring patient safety
In collaboration with IDIAP Jordi Gol
3-4 June 2024
Barcelona, Spain
Not able to attend the symposium in person?
Recordings available to purchase via registration/ Register for recordings
Explore
Registration
Registration fees below for existing members and non-members of ISoP.
| Existing Members Category | Cost |
|---|---|
| Private sector, HIC | €465.00 |
| Public sector, HIC, students | €315.00 |
| Private sector, LMIC | €315.00 |
| Public sector, LMIC, students | €215.00 |
| Non-Members Category | Cost |
|---|---|
| Private sector, HIC (includes one-year ISoP membership) |
€815.00 |
| Public sector, HIC, students (includes one-year ISoP membership) |
€450.00 |
| Private sector, LMIC (includes one-year ISoP membership) |
€450.00 |
| Public sector, LMIC, students (includes one-year ISoP membership) |
€300.00 |
* Low and Middle-Income Countries (LMICs):
Applicants must work and reside OUTSIDE the following countries (according to the World Bank classification):
Andorra, Australia, Austria, Bahrain, Belgium, Brunei Darussalam, Canada, Chile, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong SAR China, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea Rep., Kuwait, Latvia, Liechtenstein, Lithuania, Luxembourg, Macao SAR China, Malta, Monaco, Netherlands, New Zealand, Norway, Oman, Panama, Poland, Portugal, Puerto Rico, Qatar, Romania, Saudi Arabia, Singapore, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Chinese Taipei, Trinidad and Tobago, United Arab Emirates, United Kingdom, United States, Uruguay.
* Not-for-profit organisations:
National Health Authorities, National Pharmacovigilance centres, Academic institutions, Non-Governmental Organisations involved in Public Health, Public hospitals and Medical Institutions contributing to the Public Health System.
* Commercial organisations:
Pharmaceutical industry, CROs, Private hospitals, and other commercial organisations (private sector).
